Pregnancy is associated with significant, but reversible changes in thyroid function studies, which are among the most profound seen as a result of a normal physiologic state. The present study was carried out to find out alterations in thyroid function tests in each trimester in normal pregnant women as compared to non-pregnant women in Tabriz-lran. A case-control study designed with 229 normal pregnant women that randomly selected from the first (64 samples), the second (92 samples), and the third (73 samples) trimesters and 250 randomly selected non-pregnant healthy female controls. Age range in both groups was 16-40 years. Thyroid function tests carried out by measuring serum levels of thyroid stimulating hormone (TSH), free and total thyroxin (FT 4, TT4), and free and total triiodothyronine (FT 3, TT3) by commercially available radio immunoassay kits. We found that mean TT 4 increased progressively during pregnancy. Our study showed increasing in serum levels of TT 3 in the second trimester and then declining during the third trimester compared with non-pregnant women. We showed that FT 4 strongly decreased during the third trimester. Free T 3 showed declining in the second and third trimesters. Mean TSH did not show significant difference in each trimester compared with non-pregnant women. The thyroid function tests in pregnancy should be interpreted against gestational age-related reference intervals to avoid mis-interpretation of thyroid function during pregnancy.
INTRODUCTION
Pregnancy is associated with significant, but reversible changes in thyroid function studies, which are among the most profound seen as a result of a normal physiologic state (1) (2) (3) (4) (5) (6) . Furthermore, human chronic gonadotropin (hCG) can stimulate the thyroid gland during first trimester because of its structural similarity to thyrotrophin (TSH) (7) . Thyroid hormones having important role in embryogenesis and fetal development during pregnancy (8) (9) (10) . Therefore, thyroid status is frequently assessed during pregnancy, both to evaluate suspected thyroid abnormalities, and to monitor the status of pre-existing thyroid disease. However, the usual clinical and laboratory assessment can be potentially misleading.
The findings associated with the hypermetabolic state of normal pregnancy can overlap with the clinical signs and symptoms of thyroid disease. Both normal pregnancy, and pregnancy complicated by conditions such as hyperemesis gravidarum (HG), can be associated with thyroid function study changes that are strongly suggestive of hyperthyroidism, in the absence of primary thyroid disease (5, 11, 12) . Therefore, a local reference range for thyroid hormones in pregnant women is needed (13-18). The availability of gestational age-dependent reference intervals for thyroid hormones for local population should help to avoid the underdiagnosis of hyperthyroidism or the overdiagnosis of hypothyroidism, with inadvertent use of thyroxine replacement in later pregnancy. It also allows an accurate interpretation of thyroid hormone results in complicated pregnancies, which may have abnormal thyroid function, such as pre-eclampsia and HG (13, 15, 18) . Therefore, We designed a crossectional case-control study with systematic random sampling to find out alterations in thyroid function tests in each trimester in normal pregnant women as compared to non-pregnant women in Tabriz-lran.
MATERIALS AND METHODS

Subjects
The case group consisted of 229 pregnant women without pre-existing thyroid disease, hyperemesis gravidarum (HG), trophoblastic disease or preclampsia that randomly selected from women during the first (64 samples), the second (92 samples), and the third (73 samples) trimesters. The control group comprised 250 randomly selected non-pregnant healthy females at childbearing age. All subjects were consuming iodide salt. Therefore, no one of the subjects had iodide deficiency problem. Age range in both groups was 16-40 years.
Blood sampling and hormones analyses
Five milliliters of blood were collected between 0800-0900 h in the morning from both patient and control group. Then, thyroid function tests carried out by measuring serum levels of thyroid stimulating hormone (TSH), free and total thyroxin (FT 4, TT4), and free and total triiodothyronine (FT 3, TT3) using commercially available radio immunoassay kits (DPC, USA) on Gammamatic II gammacounter (Contron, Switzerland).
Statistical Analysis
Differences of thyroid function tests between each trimester and the control group were tested with Student's t-test. A two-sided p value <0.01 was the level of statistically significance. All data were 182-185 I expressed as mean+SD. Statistical computations were calculated using SPSS 9.0 for windows software (SPSS Tnc, Chicago, IL, USA). Table 1 shows the mean+SD of the measured thyroid function tests in pregnant women and the nonpregnant control group. We found that mean "1-1-4 levels decreased non-significantly in the first and the second trimester (p>0.01) and then increased significantly during the third trimester (p<0.01) relative to the nonpregnant women. In the first trimester, the mean TT 3 values showed declining (p>0.01), which then was increasing during the second trimester (p<0.01) and declined in the third trimester (p>0.01) relative to the control group. Mean FT 4 levels increased nonsignificantly in first trimester, and then declined during the second (p>0.01) and the third (p<0.01) trimesters. Mean FT 3 values showed declining over the trimesters relative to the non-pregnant control group that were significant in second and third trimesters (p<0.01). Mean TSH levels decreased during the first and the second trimester, and then increased in the third trimester, which no one was significant (p>0.01). We also compared mean values of each thyroid function tests during pregnancy to non-pregnant women (Table  1) . We found significantly increase in TT 4 during pregnancy. Both FT 4 and FT 3 showed significant declining during pregnancy compared to non-pregnant women. N=Number of subjects. SD=Standard deviation.
RESULTS
a=Significant increase compared to non-pregnant women: p<0.01. b= Significant decrease compared to non-pregnant women: p<0.01.
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DISCUSSION
This study showed that compared to non-pregnant women, TT 4 rose during the third trimester, whereas TT 3 increased in the second trimester. Free T 4 strongly declined during the third trimester, whereas FT 3 decreased in the second and the third trimesters. Mean TSH was seen to rise progressively through the three trimesters of pregnancy, but was not significant compared with non-pregnant women. Overall mean of each thyroid function test showed significantly increasing in TT 4 and declining FT 4 and FT 3. But, TSH and TT 3 did not show significant difference in pregnant women compared with non-pregnant women.
Khandakar MA et al. performed a case-control study to find out alteration in serum thyroid hormones levels in normal pregnant women as compared to nonpregnant women in Dhaka City (8) . For this purpose, they randomly selected 35 pregnant women during third trimester and 21 non-pregnant women of childbearing age as control. Their study showed that serum TT 4 level of non-pregnant women was normal, but in pregnant women during third trimester was significantly higher compared to non-pregnant. This finding was closely like to our study. Khandakar MA et al also found that TT 3 levels in both groups were within normal range without significant difference between them. This result was in contrast to our finding. Their finding about TSH was closely similar to our study. However, a significant limitation of Khandakar MA et al. investigation was small sample size. Panesar NS et al carried out a prospective study with 343 healthy pregnant women (5-41 weeks) and 63 non-pregnant controls to establish gestation-related reference intervals for thyroid hormones in pregnant Chinese women (13). They found that FT 3 decreased during pregnancy, whereas FT 4 initially increased, peaking between 9-13 weeks and then decreased~ the decline becoming significant by week 21, and TSH changes was similar to FT 4. We also found declining in FT 3 over the pregnancy. FT 4 changes during pregnancy in our study were nearly similar to their study. In contrast to Panesar NS et al., we did not find any significant change in TSH in each trimester compared to nonpregnant women. McEIduffA found that FT 4 decreases during pregnancy compared to non-pregnant women and resulted the need for each laboratory to develop its own normal range for FT 4 levels in pregnancy (15). Our study also showed significant declining of FT 4 during pregnancy. Kumar A et al. measured serum levels of T 3, T 4 , and TSH in 124 pregnant women that were apparently normal, healthy young primigravidas with no known metabolic disorders and normal carbohydrate gestational intolerance test (16). They found that mean TT 3 increases during the second trimester and then declines in the third trimester
182-185
compared to the first trimester. This result was also shown in our study. Kumar A et al. also showed mean TT 4 level rises in the second trimester and then decreases during the third trimester. In our study TT 4 showed increasing in both the second and the third trimester. Kumar A et al. also saw mean "FSH level rises progressively through the trimesters of pregnancy. Our study also showed this increasing through the trimesters. Erem C et al. investigated maternal thyroid function in 29 pregnant women with goiter and 51 pregnant women without goiter in the eastern black sea region of Turkey, which is an endemic goiter area (17). They found that all TT4, FT 4, TT 3, FT 3, and TBG increase during pregnancy. Erem C et al. also showed that serum TSH levels declines in pregnant women without goiter compared with nonpregnant women without goiter. In our study serum levels of TT 4, TT 3 and TSH in pregnant women showed changes closely similar to Erem C et al. But in contrast to them we seen declining in serum levels of FT 4 and FT 3 in pregnant women compared with nonpregnant women.
The etiology of increase in total circulating thyroid hormones involves, primarily, increased concentrations of plasma thyroxine binding globulin (TBG) during pregnancy (7) . Another proposed mechanism for this increase in total thyroid hormone concentrations is production of type III deiodinase from the placenta. This enzyme, which converts T 4 to reverse T3, and T 3 to diiodotyrosine (T2), has extremely high activity during fetal life. Increased demand for T 4 and T 3 has been suggested to increase production of these hormones with, ultimately, increased concentrations in the circulation (7) . Increased sialylation, mediated by oestrogens, reduces the clearance of TBG, resulting to increase levels of TT 4 and TT 3 as well (13). Changes in albumin and free fatty acid concentrations affect the binding of T 4 and T 3 to carrier proteins, lowering the blood levels of FT 4 and FT 3 as pregnancy progresses (12, 13).
In conclusion, it is important that thyroid function tests in pregnancy should be interpreted against gestational age-related reference intervals, and the result of this study could decline the possibility of the misinterpretation of thyroid function in pregnant women in our research area.
